• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[当前治疗下局部原发性乳腺癌的预后]

[Prognosis of local primary breast carcinoma under current therapy].

作者信息

Mutzner F, Amgwerd R, Gessner U

出版信息

Schweiz Med Wochenschr. 1977 Jul 16;107(28):992-4.

PMID:897642
Abstract

A retrospective study is presented on 225 selected patients with local primary carcinoma of the breast treated from 1963 to 1973 at the Surgical Clinic of the Cantonal Hospital, St. Gallen, Switzerland. All patients were under 70 years old. The results are compared of our two therapies, namely radical mastectomy of Halsted and a modified radical mastectomy consisting of mastectomy with dissection of the axilla but without removing the pectoral muscle. Both operations were followed by postoperative irradiation. In view of the short postoperative interval after modified radical mastectomy (from 1969), a five-year diseasefree survival is indicated. There was no statistically significant difference between the two therapies. Depending on age, patients with histologically negative lymph nodes of the axilla had a probability of 45-60% for 5-year diseasefree survival, against only 15-40% for those with positive axillary lymph nodes. The quality of survival is deemed important, and the authors therefore recommend the modified radical mastectomy, which disfigures a woman less than the Halsted operation.

摘要

本文对1963年至1973年期间在瑞士圣加仑州立医院外科诊所接受治疗的225例局部原发性乳腺癌患者进行了回顾性研究。所有患者年龄均在70岁以下。比较了两种治疗方法的结果,即哈尔斯德根治性乳房切除术和一种改良根治性乳房切除术,后者包括乳房切除术加腋窝清扫但不切除胸肌。两种手术均在术后进行放疗。鉴于改良根治性乳房切除术(自1969年起)术后间隔时间较短,给出了五年无病生存率。两种治疗方法之间无统计学显著差异。根据年龄,腋窝淋巴结组织学检查阴性的患者五年无病生存概率为45% - 60%,而腋窝淋巴结阳性的患者仅为15% - 40%。生存质量被认为很重要,因此作者推荐改良根治性乳房切除术,因为它对女性身体外观的破坏比哈尔斯德手术小。

相似文献

1
[Prognosis of local primary breast carcinoma under current therapy].[当前治疗下局部原发性乳腺癌的预后]
Schweiz Med Wochenschr. 1977 Jul 16;107(28):992-4.
2
Treatment of carcinoma of the breast by modified radical mastectomy.改良根治术治疗乳腺癌
Surg Gynecol Obstet. 1975 Jan;140(1):22-6.
3
[Clinical analysis of resectable breast cancer: a report of 6 263 cases].可切除乳腺癌的临床分析:6263例报告
Ai Zheng. 2005 Mar;24(3):327-31.
4
Regional nodal recurrence in the management of breast cancer patients with one to three positive axillary lymph nodes. Outcome of patients following tangential irradiation without a separate nodal field.一至三个腋窝淋巴结阳性乳腺癌患者区域淋巴结复发情况。未设独立淋巴结照射野的切线照射患者的结局。
Strahlenther Onkol. 2004 Oct;180(10):623-8. doi: 10.1007/s00066-004-1241-2.
5
Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy.采用改良的Halsted根治性乳房切除术并选择性使用放疗治疗原发性乳腺癌后,局部区域复发风险较低。
Cancer. 1999 Apr 15;85(8):1773-81.
6
Evaluation of dissection of the axilla in modified radical mastectomy.改良根治性乳房切除术中腋窝清扫的评估
Surg Gynecol Obstet. 1976 Sep;143(3):395-7.
7
Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.新辅助化疗后局部晚期乳腺癌原发肿瘤及腋窝转移淋巴结病理反应的预后意义
Cancer J Sci Am. 1998 Mar-Apr;4(2):125-31.
8
Surgical treatment of early breast cancer.早期乳腺癌的外科治疗
Med Lett Drugs Ther. 1973 Feb 16;15(4):19-20.
9
The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06.接受和未接受术后放疗的乳腺癌手术后肺癌的发病率。国家外科辅助乳腺和肠道项目(NSABP)临床试验B - 04和B - 06的结果。
Cancer. 2003 Oct 1;98(7):1362-8. doi: 10.1002/cncr.11655.
10
Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.在前哨淋巴结阴性的乳腺癌患者中省略腋窝淋巴结清扫术是安全的:一项长期随访分析。
J Surg Oncol. 2004 Oct 1;88(1):4-7; discussion 7-8. doi: 10.1002/jso.20101.